New Gel-Like wrap could stop chronic pain after cancer reconstruction
NCT ID NCT07558096
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times
Summary
This pilot study tests whether placing a soft tissue matrix over a nerve during forearm flap surgery can prevent chronic pain and numbness. Eighty head and neck cancer patients will be randomly assigned to receive either the matrix or standard closure. The main goal is to see if the matrix reduces neuropathic pain six months after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Avive+ soft tissue matrix
- What this could lead to
- If it works, this could offer a simple way to prevent long-term nerve pain and numbness after reconstructive surgery for head and neck cancer.
- What could go wrong
- This is a small pilot study (80 people) that hasn't started yet. The matrix may not reduce pain better than standard closure, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER (H&N) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain games may rev up thinking and driving after cancer treatment
- New imaging tracer could spot hidden cancers and fibrosis in one scan
- Heat and pulses: new combo therapy aims to soften cancer Treatment's harsh toll
- Bacteria in the mouth and gut may predict who responds to cancer immunotherapy
- Glowing dye may save surgical flaps in head and neck cancer patients
- New radioactive tracers could spot cancers more clearly